Skip to content
GenoLensGenoLens

PRDM5

Chr 4q27

PR/SET domain 5

Aliases:
PFM2
MANE:
ENST00000264808.8

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Corneal abnormalities

    BIALLELIC, autosomal or pseudoautosomal
  • Corneal dystrophy

    BIALLELIC, autosomal or pseudoautosomal
  • Ehlers Danlos syndrome with a likely monogenic cause

    BIALLELIC, autosomal or pseudoautosomal
  • Structural eye disease

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • brittle cornea syndrome

    0.78
  • Abnormality of the cardiovascular system

    0.51
  • Connective tissue disease with eye involvement

    0.50
  • osteoarthritis, knee

    0.41
  • Ehlers-Danlos syndrome

    0.41
  • smoking initiation

    0.37
  • type 2 diabetes mellitus

    0.35
  • osteoarthritis

    0.34
  • alcohol drinking

    0.31
  • DNA methylation

    0.31

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

PR domain zinc finger protein 5

Sequence-specific DNA-binding transcription factor. Represses transcription at least in part by recruitment of the histone methyltransferase EHMT2/G9A and histone deacetylases such as HDAC1. Regulates hematopoiesis-associated protein-coding and microRNA (miRNA) genes. May regulate the expression of proteins involved in extracellular matrix development and maintenance, including fibrillar collagens, such as COL4A1 and COL11A1, connective tissue components, such as HAPLN1, and molecules regulating cell migration and adhesion, including EDIL3 and TGFB2. May cause G2/M arrest and apoptosis in cancer cells

Curated MONDO disease pages that list PRDM5 among their top associated genes.

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.